Catalyst Pharmaceuticals, Inc. (CPRX) Social Stream



Catalyst Pharmaceuticals, Inc. (CPRX): $6.87

-0.05 (-0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Catalyst Pharmaceuticals Inc (CPRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Catalyst Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-05 5 $11 $6.5 $8.5 $8.33 2.04%
2021-11-11 5 $12 $7 $9.6 $8.33 15.25%
2022-01-13 5 $12 $7 $9.8 $8.33 17.65%
2022-03-18 5 $12 $8 $11 $8.33 32.05%
2022-03-27 5 $12 $8.75 $10.95 $8.33 31.45%

The Trend in the Analyst Price Target


CPRX's average price target has moved up $2.65 over the prior 29 weeks.

Over the past 50 weeks, CPRX's average upside potential has been 46.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 0 9 5.5 7.5 4.44 68.92%
2021-05-22 0 9 5.5 7.5 5.70 31.58%
2021-08-07 0 11 5.5 8.1 5.81 39.41%
2021-09-20 0 11 6.5 8.3 4.85 71.13%
2022-01-13 5 12 7.0 9.8 6.14 59.61%

CPRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


CPRX's average broker recommendation rating improved by 0 over the prior 59 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Catalyst Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is greater than 43.76% of that group.
  • In terms of how Catalyst Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 53.2% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Catalyst Pharmaceuticals Inc's number of analysts covering the stock is greater than 319.3% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Catalyst Pharmaceuticals Inc's variance in analysts' estimates is lower than -85.82% of them.

Stocks similar to Catalyst Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CPIX, COLL, and COGT.

Is CPRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.2702 seconds.